Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac

Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac

<p dir="ltr">Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac. A, B) The top significantly down (A) and up (B) regulated GO pathways in AD-MSC in comparison with PSCs treated with Muc5ac-proficient (KCT3266) or deficient (KCT3266 Muc5ac KO) CM. C, D) T...

Saved in:

书目详细资料
主要作者:	Sushil Kumar (20371917) (author)
出版:	2025
主题:	Cancer cell biology pancreatic cancer CAF heterogeneity epigenetics Muc5ac stroma
标签:	添加标签没有标签, 成为第一个标记此记录!

相似书籍

Supplementary Figure 1: Activation of AD-MSCs and PSCs by Muc5ac
由: Sushil Kumar (20371917)
出版: (2025)

Supplementary Figure 4: RNA-sequencing in the primary AD-MSCs, BM-MSCs, and PSCs after treatment with KC and KCM serum
由: Sushil Kumar (20371917)
出版: (2025)

Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
由: Sushil Kumar (20371917)
出版: (2025)

Supplementary Figure 6: Age-dependent differences in CAF activation
由: Sushil Kumar (20371917)
出版: (2025)

Supplementary Tables
由: Sushil Kumar (20371917)
出版: (2025)

Data Sheet 1_Quantum tunneling and barrier hopping in MgTi2O5 nanoparticles: a study of AC/DC conductivity and dielectric response.pdf
由: A. S. Salwa (22686665)
出版: (2025)

Processed single-cell RNA-seq dataset of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 therapy
由: Thang Pham (19938126)
出版: (2025)

Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
由: Jiachun Su (16990970)
出版: (2025)

Supplementary Table 1 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
由: Emily K.W. Lo (15618846)
出版: (2025)

Supplementary Table 2 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
由: Emily K.W. Lo (15618846)
出版: (2025)

Supplementary Table 3 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
由: Emily K.W. Lo (15618846)
出版: (2025)

Supplementary Table 4 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
由: Emily K.W. Lo (15618846)
出版: (2025)

Supplementary Table 5 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
由: Emily K.W. Lo (15618846)
出版: (2025)

Supplementary Table 6 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
由: Emily K.W. Lo (15618846)
出版: (2025)

Supplementary Table 7 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
由: Emily K.W. Lo (15618846)
出版: (2025)

Schematic of added myelinated axon.
由: Nicholas Hananeia (22683665)
出版: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
由: Erika Y. Faraoni (14844897)
出版: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
由: Erika Y. Faraoni (14844897)
出版: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
由: Erika Y. Faraoni (14844897)
出版: (2025)

Development of [89Zr]Zr-DFO-hu3F8 and [225Ac]Ac-DOTA-hu3F8 Theranostic Pairs Targeting GD2 in Neuroblastomas
由: Lingling Zheng (1628176)
出版: (2025)

Supplementary Data 1 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
由: Gregory L. Beatty (15087193)
出版: (2025)

Supplementary Data 2 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
由: Gregory L. Beatty (15087193)
出版: (2025)

Image 9_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
由: Xiangjun Wang (2522917)
出版: (2025)

Image 8_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
由: Xiangjun Wang (2522917)
出版: (2025)

Image 6_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
由: Xiangjun Wang (2522917)
出版: (2025)

Image 7_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
由: Xiangjun Wang (2522917)
出版: (2025)

Image 4_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
由: Xiangjun Wang (2522917)
出版: (2025)

Image 5_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
由: Xiangjun Wang (2522917)
出版: (2025)

Image 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
由: Xiangjun Wang (2522917)
出版: (2025)

Image 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
由: Xiangjun Wang (2522917)
出版: (2025)

Image 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
由: Xiangjun Wang (2522917)
出版: (2025)

Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
由: Xiangjun Wang (2522917)
出版: (2025)

Table 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
由: Xiangjun Wang (2522917)
出版: (2025)

Table 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
由: Xiangjun Wang (2522917)
出版: (2025)

Supplementary Table S1 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer
由: Nan Ding (15321526)
出版: (2025)

Supplementary Table S2 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer
由: Nan Ding (15321526)
出版: (2025)

Directed differentiation of human iPSCs into region-specific intestinal (HIOs) and colonic (HCOs) organoids.
由: Elizabeth Y. Flores (22676699)
出版: (2025)

Supplementary Movie S1 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S2 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S3 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_c7ktbk3cgv32i6tufad8ca41e2